Concepedia

Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group

Nicolás Mendoza, Isabel Ramírez, Esther de la Viuda, Pluvio Coronado, Laura Baquedano, Plácido Llaneza, Verónica Balsera Nieto, Borja Otero, Sonia Sánchez, Visitación Álvarez de Frutos,

Maturitas · 2022 · 44 citations · 204 references

DOI

Concepts

References

204

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher, Alessandro Liberati, Jennifer Tetzlaff et al. · PLoS Medicine · 2009 · 64.1K citations · Full text

, , +11

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

Jonathan A C Sterne, Miguel A. Hernán, Barnaby C Reeves et al. · BMJ · 2016 · 19K citations · Full text

, , +15

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

JAMA · 2002 · 15.8K citations · Full text

, , +17

Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women’s Health Initiative Randomized Trials

JoAnn E. Manson, Rowan T. Chlebowski, Marcia L. Stefanick et al. · JAMA · 2013 · 1.6K citations · Full text

, , +15

Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis

David M. Herrington, David M. Reboussin, K. Bridget Brosnihan et al. · New England Journal of Medicine · 2000 · 1.3K citations · Full text

, , +17